⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 15 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 52 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 15 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 52 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine EU August 24, 2023

Tresiba

📷 Wikipedia: Insulin degludec
Tresiba
📷 Wikipedia: Insulin degludec
INN
insulin degludec
Forms
Pre-filled pen
Strengths
100 units/ml ;200 units/ml
Area
Diabetes Mellitus
Alternatives
Yes
🗄
Archived (older alert)
This alert was reported 1068 days ago and has been moved from our active feed to the archive. The original safety information still applies — we have no confirmation from the issuing agency that the product is safe again. Refer to the official notice for the current status.
📈 Timeline
72 days in total
May 16, 2026 July 27, 2026
Daily snapshot data starts accumulating once the scheduler runs — for now this is interpolated from the agency's first/last dates.

What is this? Tresiba is a medicine for diabetes. It comes as a pen you use to inject insulin.

What's happening? There is a shortage of Tresiba pens right now. Supplies may be low in some places.

Does this affect me? If you use Tresiba, you might have trouble getting it. Ask your pharmacist if other options are available.

What should I do? Do not stop your medicine without talking to your doctor or pharmacist first.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
insulin degludec
Brand(s) / product name(s)
Tresiba
Agency-published detail

INN: insulin degludec · Forms: Pre-filled pen · Strengths: 100 units/ml ;200 units/ml · Area: Diabetes Mellitus · Alternatives: Yes

First published
August 24, 2023
Last refreshed by us
2 months ago
Severity (as classified)
Medium
Official source
https://www.ema.europa.eu/en/medicines/human/shortages/tresiba

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Tresiba. INN: insulin degludec · Forms: Pre-filled pen · Strengths: 100 units/ml ;200 units/ml · Area: Diabetes Mellitus · Alternatives: Yes
▸ When was this alert issued?
This alert was issued on August 24, 2023 by EMA (European Medicines Agency).
▸ Which countries are affected?
The alert applies to the entire EU.
▸ How serious is this alert?
Medium risk. A medium risk means harm is possible under certain conditions. Read the notice and act on the recommended steps.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on www.ema.europa.eu.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.